QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Fisetin decreases TET1 activity and CCNY/CDK16 promoter 5hmC levels to inhibit the proliferation and invasion of renal cancer stem cell 期刊论文 JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 卷号: 23, 期号: 2 作者:  Si, Yibing;  Liu, Junfeng;  Shen, Hongliang;  Zhang, Chen;  Wu, Yuanhao 收藏  |  浏览/下载：25/0  |  提交时间：2019/12/05 5-hydroxymethylation  cell cyclin-dependent kinases  fisetin  renal cancer stem cells   Fisetin decreases TET1 activity and CCNY/CDK16 promoter 5hmC levels to inhibit the proliferation and invasion of renal cancer stem cell 期刊论文 JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 卷号: 23, 期号: 2 作者:  Si, Yibing;  Liu, Junfeng;  Shen, Hongliang;  Zhang, Chen;  Wu, Yuanhao 收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05 5-hydroxymethylation  cell cyclin-dependent kinases  fisetin  renal cancer stem cells   RETRACTION: Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression (Retraction of Vol 36, Pg 97, 2017) 其他 2019-01-01 作者:  Wang, Yitao;  Qin, Xian;  Guo, Tao;  Liu, Pengpeng;  Wu, Ping 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05 Long non-coding RNA KCNQ1OT1 mediates the growth of hepatocellular carcinoma by functioning as a competing endogenous RNA of miR-504 期刊论文 INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 卷号: 52, 页码: 1603-1612 作者:  Li, Chao;  Miao, Runchen;  Zhang, Jingyao;  Qu, Kai;  Liu, Chang 收藏  |  浏览/下载：3/0  |  提交时间：2019/11/26 CDK16  microRNA-504  growth  hepatocellular carcinoma  lncRNA KCNQ1OT1   Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression 期刊论文 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 卷号: 36 作者:  Wang, Yitao;  Qin, Xian;  Guo, Tao;  Liu, Pengpeng;  Wu, Ping 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 Hepatocellular carcinoma (HCC)  Cyclin dependent Kinase 16 (CDK16)  Epithelial mesenchymal transition (EMT)  E2F1 transcription factor  miR-125b-5p